76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Jazz Pharmaceuticals PLC
Closed
SectorHealthcare
112.42 0.73
Overview
Share price change
24h
Min
109.16
Max
112.6
Income | -284M -93M |
|---|---|
Sales | -190M 898M |
P/E Sector Avg | 14.62 39.564 |
Profit margin | -10.307 |
Employees | 2,800 |
EBITDA | -275M 109M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +61.86% upside |
Next Earnings | 30 Jul 2025 |
|---|
Market Cap | -776M 6.6B |
|---|---|
Previous open | 111.69 |
Previous close | 112.42 |
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Jazz Pharmaceuticals PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Jazz Pharmaceuticals PLC Forecast
Price Target
By TipRanks
61.86% upside
12 Months Forecast
Average 176.64 USD 61.86%
High 230 USD
Low 121 USD
Based on 14 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
